Morgan Lewis Advised Eurazeo On Investment In Excelya

Morgan Lewis represented Eurazeo, a leading European investment group, in its investment in Excelya, a European clinical

Update: 2025-12-06 04:30 GMT


Morgan Lewis Advised Eurazeo On Investment In Excelya

Morgan Lewis adviced Eurazeo, a leading European investment group, in its investment in Excelya, a European clinical research services provider. The investment sees Eurazeo join Excelya as a long-term investor alongside its management team.

With €37.4 billion in diversified assets under management, Eurazeo supports more than 600 mid-market companies. Excelya develops ways of treating patients and advancing scientific, managerial, and human knowledge in the field of clinical research.

The Morgan Lewis team was led by advised Eurazeo includes Sophie Perus (Partner), Sebastien Pontillo (Partner), and Thomas Lefebvre (Counsel), and Baptiste Godmer (Associate), Charles Deffontaines (Associate), Camille Jannin (Associate).

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.

Tags:    

Similar News